GLAND PHARMA
Back to Cashflow Statement
|
GLAND PHARMA Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Operating Activities | ₹997 Cr | ₹364 Cr | ₹791 Cr | ₹605 Cr | ₹701 Cr |
What is the latest Cash Flow from Operating Activities ratio of GLAND PHARMA ?
Year | Cash Flow from Operating Activities |
---|---|
Mar2024 | ₹997 Cr |
Mar2023 | ₹364 Cr |
Mar2022 | ₹791 Cr |
Mar2021 | ₹605 Cr |
Mar2020 | ₹701 Cr |
How is Cash Flow from Operating Activities of GLAND PHARMA Trending?
Years | Cash Flow from Operating Activities | % Change | |
---|---|---|---|
Mar2024 | ₹997 Cr | 173.87 | |
Mar2023 | ₹364 Cr | -53.97 | |
Mar2022 | ₹791 Cr | 30.72 | |
Mar2021 | ₹605 Cr | -13.70 | |
Mar2020 | ₹701 Cr | - |
Compare Cash Flow from Operating Activities of peers of GLAND PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLAND PHARMA | ₹31,124.1 Cr | 0.1% | 11.8% | -6.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹403,580.0 Cr | 0.6% | -0.4% | 4.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹180,069.0 Cr | -2.2% | 1.7% | 47.3% | Stock Analytics | |
CIPLA | ₹119,919.0 Cr | -0.2% | -1.4% | -1.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹115,310.0 Cr | 2.5% | 4.8% | 12.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,402.0 Cr | -2.6% | -8.1% | -4.9% | Stock Analytics |
GLAND PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLAND PHARMA | 0.1% |
11.8% |
-6.3% |
SENSEX | -1.4% |
0.7% |
2.4% |
You may also like the below Video Courses